These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia].
    Author: Sugino Y, Fukuzawa S, Takeuchi H, Taki Y, Hashimura T, Soeda T, Araki I.
    Journal: Hinyokika Kiyo; 2003 Aug; 49(8):445-9. PubMed ID: 14518379.
    Abstract:
    We studied the efficacy of naftopidil (50 mg/day) on nocturia associated with benign prostatic hyperplasia in 35 patients (62-80 years old). The patients had BPH > 20 ml, nocturia, more than 3 times, international prostate symptom score (IPSS) > 7, quality of life score (QOL) < 1, and maximum flow rate (Qmax) < 15 ml/sec. They received naftopidil for more than 6 weeks. IPSS, QOL, Qmax, micturition volume, and side effects were analyzed. Naftopidil was effective for nocturia associated with benign prostatic hyperplasia, especially when taken at night.
    [Abstract] [Full Text] [Related] [New Search]